Antiinflammatory and immunoregulatory pyrimidines, their method of use
申请人:Pfizer Inc.
公开号:US04246263A1
公开(公告)日:1981-01-20
A series of 4-(2-hydroxyethylthiomethyl)pyridines and related compounds, and their pharmaceutically acceptable acid addition salts, having antiinflammatory and immunoregulatory activity are disclosed. Preferred compounds include 4-(2-hydroxyethylthiomethyl)pyridine itself, as well as 4-(2-hydroxyphenylthiomethyl)pyridine, 4-(2-hydroxy-1-propylthiomethyl)pyridine, 4-(3-hydroxy-2-butylthiomethyl)pyridine, 4-(2-hydroxyethylthiomethyl)pyrimidine, the acetate esters corresponding to the above compounds, and 4-(2,3-dihydroxy-1-propylthiomethyl)pyridine.
Prolactin secretion stimulating agents including e.g. 1,10'αβ- dimethyl-9,10-dihydro-ergocristine, Domperidone, Sulpiride, 2-mercaptoethanol, 2-hydroxyethyl 4-pyridylmethyl sulfide, 2,2'-dithio-ethanol and S,S'-ethylene- bis-(2-dithioethanol); are useful as hair growth stimulating agents. This novel use as well as novel compositions comprising prolactin secretion stimulating agents for use in the stimulation of hair growth are described and claimed.
A pharmaceutical composition containing a compound of Formula (I) for treating an opioid receptor-associated condition. Also disclosed is a method for treating an opioid receptor-associated condition using such a compound. Further disclosed are two sets of thiazolidinone compounds of formula (I): (i) compounds each having an enantiomeric excess greater than 90% and (ii) compounds each being substituted with deuterium.